Gentamycin
Choledocholithiasis
National University of MalaysiaPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Choledocholithiasis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MIDAZOLAM National University of Malaysia | Phase 4 | BBB |
Meperidine National University of Malaysia | Phase 4 | BBB |
ETOMIDATE Cheju Halla General Hospital | Phase 4 | BB |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE National University of Malaysia | Phase 2 | B |
CEFOXITIN Yonsei University | N/A | D |
Same molecule, other indications
Gentamycin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →